Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12 Pt 2
|
| pubmed:dateCreated |
1992-3-12
|
| pubmed:abstractText |
There are a variety of radiopharmaceuticals that can be used to perform captopril renography effectively. We examined a number of technetium and iodine compounds and the circumstances under which each radiopharmaceutical compound is the compound of choice. Considerations of cost, ease of use, reliability, dosage, and the effects of different protocols were all examined.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0895-7061
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
747S-748S
|
| pubmed:dateRevised |
2009-2-24
|
| pubmed:meshHeading |
pubmed-meshheading:1777190-Captopril,
pubmed-meshheading:1777190-Humans,
pubmed-meshheading:1777190-Hypertension, Renovascular,
pubmed-meshheading:1777190-Iodine Radioisotopes,
pubmed-meshheading:1777190-Iodohippuric Acid,
pubmed-meshheading:1777190-Organotechnetium Compounds,
pubmed-meshheading:1777190-Radioisotope Renography
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
Report of the Working Party Group on Determining the Radionuclide of Choice.
|
| pubmed:affiliation |
Albert Einstein College of Medicine, Bronx, NY 10461.
|
| pubmed:publicationType |
Journal Article,
Review,
Consensus Development Conference
|